Name | Number of supported studies | Average coverage | |
---|---|---|---|
enterocyte | 6 studies | 22% ± 2% | |
epithelial cell | 6 studies | 33% ± 11% | |
goblet cell | 4 studies | 24% ± 4% |
Insufficient scRNA-seq data for expression of MARVELD3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 986.97 | 328 / 328 | 99% | 10.04 | 176 / 178 |
prostate | 93% | 519.94 | 227 / 245 | 100% | 12.26 | 502 / 502 |
thymus | 100% | 445.38 | 652 / 653 | 91% | 5.90 | 552 / 605 |
lung | 87% | 198.01 | 503 / 578 | 97% | 9.08 | 1126 / 1155 |
liver | 100% | 298.97 | 225 / 226 | 77% | 5.34 | 313 / 406 |
kidney | 100% | 646.75 | 89 / 89 | 74% | 5.40 | 670 / 901 |
stomach | 75% | 176.53 | 268 / 359 | 97% | 11.89 | 276 / 286 |
breast | 62% | 413.28 | 285 / 459 | 99% | 11.40 | 1107 / 1118 |
intestine | 58% | 1372.37 | 563 / 966 | 98% | 14.57 | 514 / 527 |
bladder | 48% | 137.24 | 10 / 21 | 95% | 10.91 | 480 / 504 |
esophagus | 40% | 150.61 | 580 / 1445 | 96% | 9.26 | 176 / 183 |
ovary | 39% | 45.61 | 71 / 180 | 97% | 6.15 | 415 / 430 |
uterus | 17% | 27.46 | 29 / 170 | 86% | 9.11 | 393 / 459 |
tonsil | 0% | 0 | 0 / 0 | 100% | 7.40 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 4.86 | 1 / 1 |
skin | 72% | 200.53 | 1304 / 1809 | 2% | 0.07 | 8 / 472 |
brain | 10% | 8.30 | 276 / 2642 | 46% | 2.75 | 323 / 705 |
spleen | 6% | 4.51 | 14 / 241 | 0% | 0 | 0 / 0 |
adipose | 4% | 3.78 | 51 / 1204 | 0% | 0 | 0 / 0 |
adrenal gland | 0% | 0.50 | 1 / 258 | 0% | 0.04 | 1 / 230 |
blood vessel | 1% | 0.58 | 8 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 0% | 0.54 | 4 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 0.21 | 2 / 803 | 0% | 0 | 0 / 0 |
heart | 0% | 0.20 | 1 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 80 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0016567 | Biological process | protein ubiquitination |
GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
GO_0010633 | Biological process | negative regulation of epithelial cell migration |
GO_1902414 | Biological process | protein localization to cell junction |
GO_0070830 | Biological process | bicellular tight junction assembly |
GO_0050680 | Biological process | negative regulation of epithelial cell proliferation |
GO_0006970 | Biological process | response to osmotic stress |
GO_0046329 | Biological process | negative regulation of JNK cascade |
GO_0045216 | Biological process | cell-cell junction organization |
GO_0016020 | Cellular component | membrane |
GO_0031410 | Cellular component | cytoplasmic vesicle |
GO_0005923 | Cellular component | bicellular tight junction |
GO_0005634 | Cellular component | nucleus |
GO_0061630 | Molecular function | ubiquitin protein ligase activity |
GO_0031435 | Molecular function | mitogen-activated protein kinase kinase kinase binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MARVELD3 |
Protein name | MARVEL domain containing 3 MARVELD3 protein MARVEL domain-containing protein 3 |
Synonyms | MRVLDC3 |
Description | FUNCTION: As a component of tight junctions, plays a role in paracellular ion conductivity. . |
Accessions | ENST00000299952.4 [Q96A59-2] J3KSM2 Q9BSH2 ENST00000565261.1 [Q96A59-3] ENST00000567566.1 ENST00000268485.8 [Q96A59-1] Q96A59 |